Fig. 3: Effect of AAV2 gene transfer on visual acuity and RGC in ONC.

OKR recordings demonstrate significantly decreased visual acuity in eyes of ONC mice treated with AAV2-CAG.eGFP (nā=ā10; experiments performed in tripicate). Treatment with AAV2- Mice treated with AAV2-CAG.SIRT1 (nā=ā12; experiments performed in tripicate) show no significant effect on A visual acuity or B RGC survival by day 7. C Representative RGC counts by nuclear BRN3A staining. Data represented as meanā±āSEM. *Pā<ā0.05, **Pā<ā0.01 by 1-way ANOVA with Tukeyās HSD post-test.